INBRIJA (levodopa) Acorda Patent: 7,556,798 Expiration: Nov 4, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Patent E…
Drug Patent Expirations for the Week of October 31, 2021 Read Post »
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are thirteen patents protecting…
The post New patent expiration for Acorda drug INBRIJA appeared first …
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Lithuania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutic…
Which pharmaceutical companies have the most SPCs in Lithuania? Read Post »
This chart shows the pharmaceutical companies with patents in the most countries. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the greatest glo…
Which pharmaceutical companies have the greatest global patent coverage? Read Post »
Annual Drug Patent Expirations for TECFIDERA Tecfidera is a drug marketed by Biogen Inc and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent for Biogen Inc drug TECFIDERA appeared first on DrugPate…
Annual Drug Patent Expirations for LEVOTHYROXINE+SODIUM Levothyroxine Sodium is a drug marketed by Teva Pharms Usa Inc, Dr Reddys, Fresenius Kabi Usa, Maia Pharms Inc, Par Sterile Products, Piramal Critical,…
The post New patent for Custopharm Inc drug…
New patent for Custopharm Inc drug LEVOTHYROXINE SODIUM Read Post »
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are fourteen patents protecting…
The post New patent for Nalpropion drug CONTRAVE appeared fir…
This chart shows the pharmaceutical companies with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Croatia? Read Post »
This chart shows the pharmaceutical companies with the most patents in Malaysia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pat…
Which pharmaceutical companies have the most drug patents in Malaysia? Read Post »
Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent expiration for Alkermes Inc drug LYBALVI appeared first on …
New patent expiration for Alkermes Inc drug LYBALVI Read Post »
Get new actionable insights and updates from BiotechBlog
